Aurobinda pharma Q3 profit rises by 18.11 percent

Hyderabad, Feb 10 (IANS) Leading pharmaceutical company Aurobinda Pharma Ltd said it posted a standalone net profit of Rs. 465.71 crore for the quarter ending December 31, 2015 against Rs.394.27 crore posted in Q3 2014-15.

Standalone net profit grew by Rs.71.44 crore in the quarter under review, a rise of 18.11 percent.

According to the unaudited financial results posted on the Bombay Stock Exchange (BSE)on Tuesday, Aurobinda Pharma’s total income from operations rose to Rs.2,364.78 crore from Rs.2,097.99 crore.

The company incurred total expenses of Rs.1,741.53 crore against Rs.1,594.15 crore.

On a consolidated basis, Aurobinda Pharma’s net profit increased to Rs.534.65 crore from Rs.382.40 crore in Q3 2014 a” 15 while total income grew to Rs.3,495.5 crore from Rs.3,166.16 crore.

Leave a Reply

Please enter your comment!

The opinions, views, and thoughts expressed by the readers and those providing comments are theirs alone and do not reflect the opinions of www.mangalorean.com or any employee thereof. www.mangalorean.com is not responsible for the accuracy of any of the information supplied by the readers. Responsibility for the content of comments belongs to the commenter alone.  

We request the readers to refrain from posting defamatory, inflammatory comments and not indulge in personal attacks. However, it is obligatory on the part of www.mangalorean.com to provide the IP address and other details of senders of such comments to the concerned authorities upon their request.

Hence we request all our readers to help us to delete comments that do not follow these guidelines by informing us at  info@mangalorean.com. Lets work together to keep the comments clean and worthful, thereby make a difference in the community.

Please enter your name here